Table of Content

1 Study Coverage
1.1 Radiopharmaceuticals Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceuticals Market Size Growth Rate by Type, 2019 VS 2024 VS 2030
1.3 Market by Application
1.3.1 Global Radiopharmaceuticals Market Size Growth Rate by Application, 2019 VS 2024 VS 2030
1.4 Global Radiopharmaceuticals Market by Region
1.4.1 Global Radiopharmaceuticals Market by Region: 2019 VS 2024 VS 2030
1.4.2 Global Radiopharmaceuticals Revenue Market
1.5 Study Objectives
1.6 Years Considered
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease (COVID-19) Impact on Global
2 Competition by Players
2.1 Global Radiopharmaceuticals Revenue by Players
2.1.1 Global Radiopharmaceuticals Revenue by Players (2019-2024)
2.1.2 Global Radiopharmaceuticals Revenue Market Share by Players (2019-2024)
2.1.3 Global Top 5 and Top 10 Companies by Radiopharmaceuticals Revenue in 2024
2.2 Global Radiopharmaceuticals Gross Margin by Players
2.3 Analysis of Competitive Landscape
2.3.1 Players Market Concentration Ratio (CR5)
2.3.2 Global Radiopharmaceuticals Players Geographical Distribution
2.4 Mergers & Acquisitions, Expansion Plans
3 Company Overview
3.1 Bracco Imaging
3.1.1 Bracco Imaging Information
3.1.2 Bracco Imaging Overview
3.1.3 Bracco Imaging Radiopharmaceuticals Revenue and Gross Margin (2019-2024)
3.1.4 Bracco Imaging Related Developments
3.2 Bayer
3.2.1 Bayer Information
3.2.2 Bayer Overview
3.2.3 Bayer Radiopharmaceuticals Revenue and Gross Margin (2019-2024)
3.2.4 Bayer Related Developments
3.3 Mallinckrodt
3.3.1 Mallinckrodt Information
3.3.2 Mallinckrodt Overview
3.3.3 Mallinckrodt Radiopharmaceuticals Revenue and Gross Margin (2019-2024)
3.3.4 Mallinckrodt Related Developments
3.4 Nordion
3.4.1 Nordion Information
3.4.2 Nordion Overview
3.4.3 Nordion Radiopharmaceuticals Revenue and Gross Margin (2019-2024)
3.4.4 Nordion Related Developments
3.5 Triad Isotopes
3.5.1 Triad Isotopes Information
3.5.2 Triad Isotopes Overview
3.5.3 Triad Isotopes Radiopharmaceuticals Revenue and Gross Margin (2019-2024)
3.5.4 Triad Isotopes Related Developments
3.6 Lantheus
3.6.1 Lantheus Information
3.6.2 Lantheus Overview
3.6.3 Lantheus Radiopharmaceuticals Revenue and Gross Margin (2019-2024)
3.6.4 Lantheus Related Developments
3.7 IBA Group
3.7.1 IBA Group Information
3.7.2 IBA Group Overview
3.7.3 IBA Group Radiopharmaceuticals Revenue and Gross Margin (2019-2024)
3.7.4 IBA Group Related Developments
3.8 GE Healthcare
3.8.1 GE Healthcare Information
3.8.2 GE Healthcare Overview
3.8.3 GE Healthcare Radiopharmaceuticals Revenue and Gross Margin (2019-2024)
3.8.4 GE Healthcare Related Developments
3.9 China Isotope & Radiation
3.9.1 China Isotope & Radiation Information
3.9.2 China Isotope & Radiation Overview
3.9.3 China Isotope & Radiation Radiopharmaceuticals Revenue and Gross Margin (2019-2024)
3.9.4 China Isotope & Radiation Related Developments
4 Market Size by Type
4.1 Global Radiopharmaceuticals Revenue by Type
4.2 Global Radiopharmaceuticals Market Size Growth by Type 2019-2024
5 Market Size by Application
5.1 Global Radiopharmaceuticals Revenue by Application
5.2 Global Radiopharmaceuticals Market Size Growth by Application 2019-2024
6 Global Radiopharmaceuticals Market Insights
6.1 Global Radiopharmaceuticals Market Revenue 2019-2024
6.2 Global Radiopharmaceuticals Revenue by Region
6.3 Americas
6.4 Europe
6.5 Asia-Pacific
6.6 Middle East & Africa
7 Americas
7.1 Americas Radiopharmaceuticals Market Size by Country
7.1.1 Americas Radiopharmaceuticals Revenue by Country (2019-2024)
7.1.2 U.S.
7.1.3 Canada
7.1.4 Mexico
7.1.5 Brazil
7.1.6 Argentina
8 Europe
8.1 Europe Radiopharmaceuticals Market Size by Country
8.1.1 Europe Radiopharmaceuticals Revenue by Country (2019-2024)
8.1.2 Germany
8.1.3 France
8.1.4 U.K.
8.1.5 Italy
8.1.6 Russia
9 Asia Pacific
9.1 Asia Pacific Radiopharmaceuticals Market Size by Region
9.1.1 Asia Pacific Radiopharmaceuticals Revenue by Region (2019-2024)
9.1.2 China
9.1.3 Japan
9.1.4 South Korea
9.1.5 India
9.1.6 Southeast Asia
9.1.7 Australia
10 Middle East and Africa
10.1 Middle East and Africa Radiopharmaceuticals Market Size by Country
10.1.1 Middle East and Africa Radiopharmaceuticals Revenue by Country (2019-2024)
10.1.2 Turkey
10.1.3 Saudi Arabia
10.1.4 U.A.E
11 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
11.1 Radiopharmaceuticals Industry Trends
11.2 Radiopharmaceuticals Market Drivers
11.3 Radiopharmaceuticals Market Challenges
11.4 Radiopharmaceuticals Market Restraints
12 Radiopharmaceuticals Forecasted Market Size by Type
12.1 Global Radiopharmaceuticals Forecasted Revenue by Type
12.2 Global Radiopharmaceuticals Forecasted Market Size Growth by Type 2024-2030
13 Radiopharmaceuticals Forecasted Market Size by Application
13.1 Global Radiopharmaceuticals Forecasted Revenue by Application
13.2 Global Radiopharmaceuticals Forecasted Market Size Growth by Application 2024-2030
14 Global Radiopharmaceuticals Market Forecasts
14.1 Global Radiopharmaceuticals Market Revenue Forecasts 2024-2030
14.2 Global Radiopharmaceuticals Forecasts Revenue by Region
14.3 Americas
14.3.1 Americas Radiopharmaceuticals Forecasts Revenue by Country (2019-2024)
14.4 Europe
14.4.1 Europe Radiopharmaceuticals Forecasts Revenue by Country (2019-2024)
14.5 Asia-Pacific
14.5.1 Asia Pacific Radiopharmaceuticals Forecasts Revenue by Country (2019-2024)
14.6 Middle East & Africa
14.6.1 Middle East and Africa Radiopharmaceuticals Forecasts Revenue by Country (2019-2024)
15 Research Findings and Conclusion
16 Methodology and Data Source
16.1 Methodology
16.1.1 Research Process
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Legal Disclaimer